Ken Griffin
CLBT icon

Ken Griffin’s Cellebrite CLBT Stock Holding History

Ken Griffin’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.8M Buy
1,436,201
+912,442
+174% +$13.8M ﹤0.01% 2357
2025
Q4 		$9.44M Buy
523,759
+33,547
+7% +$602K ﹤0.01% 3324
2025
Q3 		$9.08M Buy
490,212
+229,503
+88% +$3.61M ﹤0.01% 3417
2025
Q2 		$4.17M Sell
260,709
-20,309
-7% -$362K ﹤0.01% 4421
2025
Q1 		$5.46M Sell
281,018
-343,461
-55% -$7.23M ﹤0.01% 3727
2024
Q4 		$13.8M Sell
624,479
-219,174
-26% -$4.22M ﹤0.01% 2580
2024
Q3 		$14.2M Buy
843,653
+319,674
+61% +$4.74M ﹤0.01% 2445
2024
Q2 		$6.26M Sell
523,979
-178,683
-25% -$2M ﹤0.01% 3407
2024
Q1 		$7.79M Buy
702,662
+185,764
+36% +$1.9M ﹤0.01% 3287
2023
Q4 		$4.48M Buy
516,898
+329,109
+175% +$2.56M ﹤0.01% 3954
2023
Q3 		$1.44M Sell
187,789
-14,518
-7% -$109K ﹤0.01% 5854
2023
Q2 		$1.46M Buy
202,307
+54,361
+37% +$317K ﹤0.01% 5727
2023
Q1 		$901K Buy
147,946
+56,216
+61% +$305K ﹤0.01% 7007
2022
Q4 		$400K Sell
91,730
-32,076
-26% -$143K ﹤0.01% 8717
2022
Q3 		$486K Sell
123,806
-42,956
-26% -$215K ﹤0.01% 8512
2022
Q2 		$850K Sell
166,762
-3,491
-2% -$18.2K ﹤0.01% 7400
2022
Q1 		$1.09M Buy
170,253
+142,863
+522% +$947K ﹤0.01% 7500
2021
Q4 		$220K Buy
27,390
+6,470
+31% +$60.9K ﹤0.01% 11642
2021
Q3 		$194K Buy
+20,920
New +$219K ﹤0.01% 12027

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ken Griffin's CLBT Position: Q1 2026 in Review

Ken Griffin increased its Cellebrite (CLBT) stake by 174% in Q1 2026, buying an estimated $13.8M and bringing the position to 1,436,201 shares worth $19.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2357.

Ken Griffin first reported a position in CLBT in Q3 2021 and has held it in 19 quarters since. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Ken Griffin held 1,436,201 shares of Cellebrite worth $19.8M as of Q1 2026.
  • Ken Griffin bought 912,442 Cellebrite shares in Q1 2026, an estimated $13.8M.
  • Cellebrite made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #2357 holding.
  • Ken Griffin first reported a position in Cellebrite in Q3 2021 and has held it in 19 quarters since.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.